These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7574848)

  • 21. Treatment of cutaneous T-cell lymphoma.
    Zackheim HS
    Semin Dermatol; 1994 Sep; 13(3):207-15. PubMed ID: 7986690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
    Ferenczi K; Yawalkar N; Jones D; Kupper TS
    Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained remission of Sézary syndrome.
    Bouwhuis SA; McEvoy MT; Davis MD
    Eur J Dermatol; 2002; 12(3):287-90. PubMed ID: 11978575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethylene-oxide-induced pruritus associated with extracorporeal photochemotherapy.
    Georgieva J; Steinhoff M; Orfanos CE; Treudler R
    Transfusion; 2004 Oct; 44(10):1532-3. PubMed ID: 15383029
    [No Abstract]   [Full Text] [Related]  

  • 25. Cutaneous cryptococcosis in a patient with cutaneous T cell lymphoma receiving therapy with photopheresis and methotrexate.
    Frieden TR; Bia FJ; Heald PW; Eisen RN; Patterson TF; Edelson RL
    Clin Infect Dis; 1993 Oct; 17(4):776-8. PubMed ID: 8268362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insights into the mechanism of action of extracorporeal phototherapy.
    Moss FM
    Transfusion; 2006 Jan; 46(1):6-8. PubMed ID: 16398723
    [No Abstract]   [Full Text] [Related]  

  • 27. Retinal toxic reactions following photopheresis.
    Vagace JM; Gervasini G; Morais F; Benitez J; Alonso N; de Argila D; Arranz I; Bajo R
    Arch Dermatol; 2007 May; 143(5):622-5. PubMed ID: 17515512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum soluble interleukin 2 receptor levels in erythrodermic cutaneous T-cell lymphoma correlate with response to photopheresis-based treatment.
    Goldman BD; Oh SK; Davis BE; Kadin ME; Poiesz BJ; Koh HK
    Arch Dermatol; 1993 Sep; 129(9):1166-70. PubMed ID: 8363402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anaphylaxis following administration of extracorporeal photopheresis for cutaneous T cell lymphoma.
    Tran J; Morris L; Vu A; Reddy S; Duvic M
    Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. U.K. national audit of extracorporeal photopheresis in cutaneous T-cell lymphoma.
    Sanyal S; Child F; Alfred A; Callaghan T; Alband N; Whittaker S; Cowan R; Parry E; Robinson S; Dunnill MGS; Wain M; Morris S; Malladi R; Tahir S; Howles A; Arumainathan A; Azurdia R; Grant-Casey J; Matin RN; Gilson D; Howell C; El-Gheriani K; Taylor P; Scarisbrick J
    Br J Dermatol; 2018 Feb; 178(2):569-570. PubMed ID: 28782100
    [No Abstract]   [Full Text] [Related]  

  • 32. Staging and management of cutaneous T-cell lymphoma.
    Scarisbrick JJ
    Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of cutaneous T-cell lymphoma: an update.
    Young JW
    J Am Osteopath Assoc; 1993 May; 93(5):591-8, 603. PubMed ID: 8314721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracorporeal photochemotherapy in long-term treatment of early stage cutaneous T-cell lymphoma.
    Rubegni P; De Aloe G; Fimiani M
    Br J Dermatol; 2000 Oct; 143(4):894-6. PubMed ID: 11069483
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of clinical and serologic predictors of response to extracorporeal photopheresis therapy in cutaneous T-cell lymphoma patients.
    Sun LD; Polly S; Ko JS; Ricci K; Hsi ED; Cooper KD; Fernandez AP
    Photodermatol Photoimmunol Photomed; 2022 Nov; 38(6):600-603. PubMed ID: 35132696
    [No Abstract]   [Full Text] [Related]  

  • 36. Multiple squamous cell carcinomas of the skin during long-term treatment with hydroxyurea.
    De Simone C; Guerriero C; Guidi B; Rotoli M; Venier A; Tartaglione R
    Eur J Dermatol; 1998 Mar; 8(2):114-5. PubMed ID: 9649662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides.
    Child FJ; Mitchell TJ; Whittaker SJ; Scarisbrick JJ; Seed PT; Russell-Jones R
    Clin Exp Dermatol; 2004 May; 29(3):231-6. PubMed ID: 15115499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracorporeal photochemotherapy in the early treatment of cutaneous T-cell lymphoma.
    Fimiani M; Rubegni P; D'Ascenzo G; Andreassi L
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):828-30. PubMed ID: 7929941
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical experience: practical management of five patients with cutaneous T-cell lymphoma (CTCL)-related symptoms.
    Dummer R; Foss F; Dreno B; Bagot M
    Semin Oncol; 2006 Feb; 33(1 Suppl 3):S26-32. PubMed ID: 16516673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis.
    Rook AH; Gottlieb SL; Wolfe JT; Vowels BR; Sood SS; Niu Z; Lessin SR; Fox FE
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():16-20. PubMed ID: 9020930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.